Maitane Asensio et al., reported relevance of the OATP1B3 in the personalized pharmacological treatment of hepatocellular carcinoma, and recommended Lt-OATP1B3 expression should be screened prior to deciding the use of anticancer drugs substrates of this carrier in the personalized treatment of HCC (Sanchez-Vicente et al., 2023). Here, SLCO1B3 is linked to hepatocellular carcinoma.